drugset / Trial / NCT05895877
Evaluate the Efficacy and Safety of Goofice® (Elobixibat) in Patients With Chronic Constipation
RandomizedParallel-groupDouble-blindTreatment
Summary
This is a double-blind, randomized, placebo-controlled trial to evaluate the efficacy and safety of Goofice® in patients with chronic constipation.
Timeline
- Start
- 2021-12-21
- Primary completion
- 2023-09-30
- Completion
- 2023-09-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Elobixibat | Small molecule | 5 mg | — |
| Comparator | Elobixibat | Small molecule | 10 mg | — |
| Comparator | Elobixibat | Small molecule | 15 mg | — |